Postoperative interstitial high-dose-rate (HDR) brachytherapy in the treatment of therapy-resistant keloids. Long-term results of AMC cohort
Completed
- Conditions
- Keloidscar-benign-tumour10040899
- Registration Number
- NL-OMON42479
- Lead Sponsor
- Radiotherapie - AMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
All patients treated with excision and adjuvant brachytherapy for a keloid at the Academic Medical Center between July 2007 and October 2014. The cohort consist of 60 patients with 70 keloids
Exclusion Criteria
Inability or unwillingness of the patient to provide informed consent or legally incompetent/incapacitated to do so
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method